Hal­loween ad­comm post­poned as FDA seeks more Ipsen da­ta on ul­tra rare dis­or­der drug can­di­date

In a new set­back for Paris-based Ipsen, the FDA is post­pon­ing an ad­comm meet­ing that was set for Oct. 31 to re­view new in­for­ma­tion on …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.